ADIPOQ and metabolic syndrome: In summary, decreased plasma adiponectin levels and carrying SNPs at certain positions (−4034, −3964 and 276) are associated with diabetic and impaired glucose tolerance as well as an increased insulin resistance index, which could increase the risk of metabolic syndrome.